CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
Viral rebound following discontinuation of antiretroviral therapy (ART) is a major obstacle for HIV cure. Here, the authors show that adoptive cellular therapy using autologous Env-specific T cells augmented by therapeutic vaccination can control viral rebound after ART interruption in a SHIV macaqu...
Guardado en:
Autores principales: | Jin Fan, Hua Liang, Xiaolin Ji, Shuo Wang, Jing Xue, Dan Li, Hong Peng, Chuan Qin, Cassian Yee, Yiming Shao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ba168e5395147c58ff5014f91356684 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
por: Anthony M. Cadena, et al.
Publicado: (2021) -
Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission
por: Xiao L. Chang, et al.
Publicado: (2021) -
Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART.
por: Jesse D Deere, et al.
Publicado: (2014) -
Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques
por: Joshua A. Eudailey, et al.
Publicado: (2018) -
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
por: Jessica Radzio-Basu, et al.
Publicado: (2019)